These are the three winners:
| Rank | Proposal | Title | First Author | Country | Final score |
|---|---|---|---|---|---|
| 1 | ICPerMed_BPR_2021_03 | Alterations in serum glutamate levels are presented as a new risk factor in Metabolic associated fatty liver Disease | Jorge Simon | Spain | 21,2 |
| 2 | ICPerMed_BPR_2021_14 | PHARMANAGEN | Jose Beloqui | Spain | 20,2 |
| 3 | ICPerMed_BPR_2021_07 | A higher platelet-to-lymphocyte ratio is prevalent in the presence of circulating tumor microemboli and is a potential prognostic factor for non-metastatic colon cancer |
Ludmilla Thomé Domingos Chinen |
Brasil | 19,8 |
Dr. Jorge Simon (Spain), Dr. Jose Beloqui (Spain) and Dr. Ludmilla Thomé Domingos Chinen (Brazil) qualified and will be invited to the ICPerMed Workshop on Personalised Medicine which will take place in Brussels on June 21st and 22nd, where they will have the chance to present their work during a plenary session for further dissemination.
Moreover, the three winners will receive a €500 worth non-cash contribution for further dissemination.
ICPerMed thanks all the participants for their commitment and is happy to invite everyone interested in participating in the new Best Practice Recognition 2022, which will close on June 30th.
Further information is available here:
ICPerMed “Best Practice in Personalised Medicine” Recognition 2021
